Your session is about to expire
← Back to Search
Monitoring System
Clinical Evaluation of the Zynex Monitoring System, Model CM-1600
N/A
Waitlist Available
Research Sponsored by Zynex Monitoring Solutions
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up recovery period following saline reinfusion (10 minutes)
Awards & highlights
No Placebo-Only Group
Summary
This trial tests if a medical device helps reduce blood loss during surgery.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ recovery period following saline reinfusion (10 minutes)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~recovery period following saline reinfusion (10 minutes)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
CM-1600 Ability to Detect Minor Blood Loss
CM-1600 Ability to Detect Saline Reinfusion
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Blood Loss and Saline InfusionExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CM-1600
2023
N/A
~450
Find a Location
Who is running the clinical trial?
Zynex Monitoring SolutionsLead Sponsor
8 Previous Clinical Trials
843 Total Patients Enrolled